Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
01 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/01/3091510/35186/en/Kura-Oncology-and-Kyowa-Kirin-Announce-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Ziftomenib-in-Adults-with-Relapsed-or-Refractory-NPM1-Mutant-AML.html
22 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/22/3087182/35186/en/Kura-Oncology-and-Kyowa-Kirin-Announce-Pivotal-Monotherapy-Data-for-Ziftomenib-in-Oral-Presentation-at-the-2025-ASCO-Annual-Meeting.html
14 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/14/3081280/35186/en/Kura-Oncology-and-Kyowa-Kirin-Announce-Combination-Data-for-Ziftomenib-in-Oral-Presentation-at-the-2025-European-Hematology-Association-EHA-Congress.html
12 Apr 2025
// FIERCE PHARMA
https://www.fiercepharma.com/manufacturing/work-massive-us-plant-continues-kyowa-kirin-wraps-construction-118m-biologics-plant
08 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/08/3057507/35186/en/Kura-Oncology-and-Kyowa-Kirin-Announce-Submission-of-New-Drug-Application-for-Ziftomenib-to-FDA.html
08 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amgen-and-kyowa-kirin-provide-top-line-results-from-rocatinlimab-phase-3-ignite-study-in-adults-with-moderate-to-severe-atopic-dermatitis-302396165.html
ABOUT THIS PAGE
Kyowa Kirin is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of 7-Hydroxystaurosporine bulk offered by Kyowa Kirin
Find a price of Istradefylline bulk offered by Kyowa Kirin
Find a price of Olopatadine Hydrochloride bulk offered by Kyowa Kirin
Find a price of RGI-2001 bulk offered by Kyowa Kirin
Find a price of Spicamycin Analog bulk offered by Kyowa Kirin
Find a price of ASKP1240 MONOCLONAL ANTIBODY DRUG SUBSTANCE AND DRUG PRODUCT bulk offered by Kyowa Kirin
Find a price of KW-6356 DRUG SUBSTANCE bulk offered by Kyowa Kirin